CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE PHOSPHODIESTERASE INHIBITORS

• 1. 磷酸酯酶抑制剂以及使用该抑制剂的调料和食品 [P] . 中国专利： CN1113378A . 1995-12-13
• 2. 复合磷酸酯酶及其提取方法,和该复合磷酸酯酶胶囊 [P] . 中国专利： CN101368176B . 2012.03.14
• 3. CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE PHOSPHODIESTERASE INHIBITORS [P] . 英国专利： GB2174696A . 1986-11-12

  机译： 循环腺苷3'，5'-磷酸磷酸酯酶抑制剂

• 4. PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF NEUROPATHY COMPRISING AN INHIBITOR OF CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE 5 AND EITHER GABAPENTIN OR PREGABALIN [P] . IL152925B . 2010-04-15

  机译： 包含环丙氨酸3'，5'-单磷酸磷酸酯酶5和加巴汀或前庭素的抑制剂的治疗神经病的药物组合物

• 5. PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF NEUROPATHY COMPRISING AN INHIBITOR OF CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE 5 AND EITHER GABAPENTIN OR PREGABALIN [P] . IL152925A . 2010-04-15

  机译： 包含环丙氨酸3'，5'-单磷酸磷酸酯酶5和加巴汀或前庭素的抑制剂的治疗神经病的药物组合物

• 1. Nogo-A receptor internalization by cyclic adenosine monophosphate in overcoming axonal growth inhibitors after stroke [J] . Rayudu Gopalakrishna, Charlotte Lin, Mark S.Kindy, 中国神经再生研究：英文版 . 2022,第001期
• 2. Nogo-A receptor internalization by cyclic adenosine monophosphate in overcoming axonal growth inhibitors after stroke [J] . Rayudu Gopalakrishna, Charlotte Lin, Mark S.Kindy, 中国神经再生研究（英文版） . 2022,第001期
• 3. Sevoflurane effects on cyclic adenosine monophosphate response element binding protein, phosphorylated cyclic adenosine monophosphate response element binding protein, and Livin expression in the cortex and hippocampus of a vascular cognitive impairment rat model [J] . Bin Wu, Ling Dan, Xianlin Zhu 中国神经再生研究（英文版） . 2009,第007期
• 4. Cyclic AMP-Specific Phosphodiesterase Inhibitor Promote Protein Synthesis of Primary Skeletal Muscle Cells Cultured in vitro [C] . The First Academic Conference of Asian Society of Traditional Veterinary Medicine(首届亚洲兽医传统医学会学术研讨会)论文集 . 2006
• 5. The Effect of Noncatalytic Cyclic-Guanosine-Monophosphate Binding Sites on Photoreceptor Phosphodiesterase 6 in the Mammalian Rod Photoresponse [D] . Sendek, Gabriela. 2018
• 6. Agar plate screening procedure for cyclic adenosine 35-monophosphate and inhibitors of cyclic nucleotide phosphodiesterase. [O] . P J Somers, C E Higgens 1977
• 7. Lowering Cyclic Adenosine-3′,5′-Monophosphate (cAMP) Levels by Expression of a cAMP-Specific Phosphodiesterase Decreases Intrinsic Pulsatile Gonadotropin-Releasing Hormone Secretion from GT1 Cells [O] . Hiroshi Yoshida, Luis Beltran-Parrazal, Paul Butler, 2003
• 8. Morphine Reduces Cerebellar Guanosine-3',5'-Cyclic Monophosphate Content and Elevates Cerebrospinal Fluid Guanosine-3',5'-Cyclic Monophosphate Content in Rhesus Monkey. [R] . Katz, J. B., Catravas, G. N., Valases, C., 1977

• 1. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension [J] . Denise Schaffner ,Adhara Lazaro ,Peter Deibert . 世界胃肠病学杂志：英文版 . 2018,第38期
• 2. Vascular endothelial growth factor B inhibits insulin secretion in MIN6 cells and reduces Ca2+ and cyclic adenosine monophosphate levels through PI3K/AKT pathway [J] . Jing-Dan Jia ,Wen-Guo Jiang ,Xu Luo . 世界糖尿病杂志：英文版（电子版） . 2021,第4期
• 3. 三磷酸腺苷、二磷酸腺苷和一磷酸腺苷的毛细管电泳分析研究 [C] . 周春喜 ,郁荣 ,吕海燕 . 第七届全国青年分析测试学术报告会 . 2002
• 4. 金葡菌丝氨酸/苏氨酸磷酸酯酶Stp1天然抑制剂靶标确证及分子互作机制研究 [A] . 杨亚楠 . 2021